tiprankstipranks
Iovance Biotherapeutics Inc (DE:2LB)
FRANKFURT:2LB

Compare Iovance Biotherapeutics (2LB) vs. Competitors

17 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Iovance Biotherapeutics
€3.32
€1.30B
-2.50
10.05%
7 Buy
3 Hold
1 Sell
Moderate Buy
KalVista Pharmaceuticals
$19.59
$993.20M
-37.98
70.50%
7 Buy
0 Hold
0 Sell
Strong Buy
Vir Biotechnology
$9.31
$1.52B
-1.91
68.35%
8 Buy
0 Hold
0 Sell
Strong Buy
Immatics
$10.43
$1.40B
-5.79
162.56%
6 Buy
0 Hold
0 Sell
Strong Buy
Nuvation Bio
$4.60
$1.60B
-14.96
136.18%
5 Buy
1 Hold
0 Sell
Strong Buy
Amylyx Pharmaceuticals Inc
$16.47
$1.81B
-7.89
351.23%
8 Buy
0 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
DE:2LB
Iovance Biotherapeutics
2.99
0.04
1.29%
KALV
KalVista Pharmaceuticals
19.59
7.57
62.98%
VIR
Vir Biotechnology
9.31
3.69
65.66%
IMTX
Immatics
10.87
6.50
148.74%
NUVB
Nuvation Bio
4.70
2.68
132.67%
AMLX
Amylyx Pharmaceuticals Inc
16.47
12.59
324.48%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts